Dr. David P. Turner serves in the Division of Surgical Oncology at the NCI-designated Massey Comprehensive Cancer Center.  He is Vice Chair of Research and Innovation in the Department of Surgery, Associate Professor in the School of Medicine at Virginia Commonwealth University. He also serves as Associate Director of Community Outreach and Engagement.

As Founder and President of the Anti-A.G.E. Foundation, Dr. Turner is internationally recognized for his leadership in cancer prevention research and education. His work centers on the role of advanced glycation end products (A.G.E.s)—a diverse group of reactive metabolites that arise from diet and lifestyle factors. The Turner Research Program is dedicated to demonstrating how increased bioavailability of A.G.E.s contributes to cancer development, treatment resistance, and disease progression.

Through his dual focus on research and community engagement, Dr. Turner is committed to translating scientific discovery into accessible education and practical strategies for cancer prevention. By bridging laboratory science with population health, he advances both innovation and equity in cancer care.